| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJPHAR.2006.09.070 |
| P698 | PubMed publication ID | 17196959 |
| P2093 | author name string | Bo-Kyung Son | |
| Katsuya Iijima | |||
| Masahiro Akishita | |||
| Masato Eto | |||
| Toru Nakano | |||
| Yasuyoshi Ouchi | |||
| Koichi Kozaki | |||
| P433 | issue | 1-3 | |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2006-10-18 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells | |
| P478 | volume | 556 |
| Q34355897 | A current understanding of vascular calcification in CKD. |
| Q24293731 | Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification |
| Q26827655 | Arterial calcification in chronic kidney disease: key roles for calcium and phosphate |
| Q38946773 | Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma |
| Q34619118 | Axl as a mediator of cellular growth and survival |
| Q33897354 | Axl tyrosine kinase protects against tubulo-interstitial apoptosis and progression of renal failure in a murine model of chronic kidney disease and hyperphosphataemia |
| Q37258717 | Biology of the TAM receptors |
| Q33706616 | Calcifying nanoparticles promote mineralization in vascular smooth muscle cells: implications for atherosclerosis |
| Q37853829 | Cell biological and physicochemical aspects of arterial calcification |
| Q34910006 | Direct effects of phosphate on vascular cell function |
| Q91659317 | Does Axl have potential as a therapeutic target in pancreatic cancer? |
| Q27319935 | Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic |
| Q46322350 | Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats |
| Q52717051 | FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis. |
| Q26798431 | From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders |
| Q33622570 | GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. |
| Q39395252 | Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications |
| Q36389223 | Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure |
| Q37615975 | High glucose induces human endothelial dysfunction through an Axl-dependent mechanism |
| Q58727283 | Investigating potential mediator between statin and coronary artery calcification |
| Q41855705 | Kruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells |
| Q36142207 | Mechanisms and clinical consequences of vascular calcification |
| Q90482437 | Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling |
| Q26753184 | Mechanisms of Vascular Calcification: The Pivotal Role of Pyruvate Dehydrogenase Kinase 4 |
| Q50333234 | MiR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway |
| Q36314694 | MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification |
| Q54632392 | Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway |
| Q39646548 | Perturbation of specific pro-mineralizing signalling pathways in human and murine pseudoxanthoma elasticum |
| Q37571935 | Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells |
| Q55507997 | Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1. |
| Q35043828 | Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting |
| Q53060301 | Plasma growth arrest-specific protein 6 levels in premenopausal and postmenopausal women: the role of endogenous estrogen. |
| Q33727722 | Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia |
| Q62046431 | Regulatory mechanisms in vascular calcification |
| Q34624641 | Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates. |
| Q37113207 | Serum sex hormone and growth arrest-specific protein 6 levels in male patients with coronary heart disease |
| Q64241686 | Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia |
| Q93069882 | TAM receptors in cardiovascular disease |
| Q92256319 | Testosterone replacement therapy and cardiovascular risk |
| Q55515015 | The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function. |
| Q89895577 | The Inhibitory Roles of Vitamin K in Progression of Vascular Calcification |
| Q54462422 | Thrombomodulin, a novel molecule regulating inorganic phosphate-induced vascular smooth muscle cell calcification. |
| Q24300740 | Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein |
| Q37122103 | Vitamin K-dependent actions of Gas6. |
| Q37170124 | Vitamin K-dependent proteins, warfarin, and vascular calcification |
| Q88636831 | Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review) |
| Q46285796 | miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment |
| Q37295751 | α-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway |
Search more.